Cargando…

Plasma proteome in multiple sclerosis disease progression

BACKGROUND: The pathophysiology of multiple sclerosis disease progression remains undetermined. The aim of this study was to identify differences in plasma proteome during different stages of MS disease progression. METHODS: We used a multiplex aptamer proteomics platform (Somalogic) for sensitive d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malekzadeh, Arjan, Leurs, Cyra, van Wieringen, Wessel, Steenwijk, Martijn D., Schoonheim, Menno M., Amann, Michael, Naegelin, Yvonne, Kuhle, Jens, Killestein, Joep, Teunissen, Charlotte E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651845/ https://www.ncbi.nlm.nih.gov/pubmed/31364818 http://dx.doi.org/10.1002/acn3.771

Ejemplares similares

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
por: Bridel, Claire, et al.
Publicado: (2018)

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment
por: Leurs, Cyra E, et al.
Publicado: (2017)

Dynamic functional connectivity as a neural correlate of fatigue in multiple sclerosis
por: Tijhuis, Floris B., et al.
Publicado: (2021)

Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis
por: Sestito, Claudia, et al.
Publicado: (2021)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

Gray matter networks and cognitive impairment in multiple sclerosis
por: Rimkus, Carolina M, et al.
Publicado: (2018)

Blood platelet RNA enables the detection of multiple sclerosis
por: Sol, Nik, et al.
Publicado: (2020)

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Long-range connections are more severely damaged and relevant for cognition in multiple sclerosis
por: Meijer, Kim A, et al.
Publicado: (2020)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

The plasma peptides of Alzheimer’s disease
por: Florentinus-Mefailoski, Angelique, et al.
Publicado: (2021)

Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2022)

Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis
por: Bouman, Piet M, et al.
Publicado: (2020)

The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing
por: van Kempen, Zoé LE, et al.
Publicado: (2017)

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study
por: Tewarie, Prejaas, et al.
Publicado: (2018)

gMS-Classifier1 does not predict disability progression in multiple sclerosis
por: van Rossum, Johannis A, et al.
Publicado: (2018)

Structural network topology relates to tissue properties in multiple sclerosis
por: Kiljan, Svenja, et al.
Publicado: (2018)

Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis
por: Broos, Jelle Y., et al.
Publicado: (2023)

Brain atrophy measurement over a MRI scanner change in multiple sclerosis
por: Sinnecker, Tim, et al.
Publicado: (2022)

Death Anxiety and Attitudes towards Death in Patients with Multiple Sclerosis: An Exploratory Study
por: Francalancia, Jara, et al.
Publicado: (2021)

Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients
por: Leurs, Cyra E, et al.
Publicado: (2017)

Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Central nervous system atrophy predicts future dynamics of disability progression in a real‐world multiple sclerosis cohort
por: Tsagkas, Charidimos, et al.
Publicado: (2021)

Adipokines in multiple sclerosis patients are related to clinical and radiological measures
por: Loonstra, Floor C., et al.
Publicado: (2022)

A randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity?
por: Prouskas, Stefanos E, et al.
Publicado: (2022)

Information processing speed in multiple sclerosis: Relevance of default mode network dynamics
por: van Geest, Q., et al.
Publicado: (2018)

Longitudinal patterns of cortical thinning in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2020)

Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients
por: Sestito, Claudia, et al.
Publicado: (2018)

Growth differentiation factor 15 is increased in stable MS
por: Amstad, Andrea, et al.
Publicado: (2020)

Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy
por: Steenwijk, Martijn D., et al.
Publicado: (2017)

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis
por: Chatterjee, Madhurima, et al.
Publicado: (2018)

Fatigue in Patients with Multiple Sclerosis: Is It Related to Pro- and Anti-Inflammatory Cytokines?
por: Malekzadeh, Arjan, et al.
Publicado: (2015)

Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures
por: Gaetani, Lorenzo, et al.
Publicado: (2022)

Regional Cerebellar Volume Loss Predicts Future Disability in Multiple Sclerosis Patients
por: Parmar, Katrin, et al.
Publicado: (2021)

Network Collapse and Cognitive Impairment in Multiple Sclerosis
por: Schoonheim, Menno M., et al.
Publicado: (2015)

Longitudinal changes of deep gray matter shape in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2022)

In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?
por: Kilsdonk, Iris D, et al.
Publicado: (2017)

Diurnal Cortisol Secretion Is Not Related to Multiple Sclerosis-Related Fatigue
por: Malekzadeh, Arjan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d2usev1lieaf0g972c21k52hqs